Home > Research Areas > Infection > Bacterial Infection
Cat. No. Product name CAS No.
DC12012 PD 404182

A heterocyclic iminobenzothiazine derivative with antimicrobial and anti-inflammatory properties, a potent inhibitor of human DDAH1 activity (IC50=9 uM) and elevates cellular ADMA levels.

72596-74-8
DC10513 AFN-1252(Debio 1452) Featured

AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml.

620175-39-5
DC9827 AN3365(Epetraborole) Featured

AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics.

1234563-16-6
DCAPI1362 Azithromycin (Zithromax)

Azithromycin (Zithromax)

83905-01-5
DC8809 Bedaquiline fumarate Featured

Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis.

845533-86-0
DC4143 Besifloxacin HCl Featured

Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic.

405165-61-9
DCAPI1024 Cefditoren pivoxil

Cefditoren pivoxil

117467-28-4
DC8937 Clarithromycin

Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.

81103-11-9
DC10612 Delpazolid (LCB01-0371) Featured

Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone.

1219707-39-7
DC1057 Fidaxomicin (Dificid) Featured

Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics.

873857-62-6
DC10307 Framycetin

Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM.

119-04-0
DC8929 Garenoxacin

Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.

194804-75-6
DC8893 Garenoxacin Mesylate hydrate

Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.

223652-90-2
DC10161 Gepotidacin

Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.

1075236-89-3
DC8928 Minocycline hydrochloride

Minocycline is a tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects.

13614-98-7
DC4226 Moxifloxacin hydrochloride

Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent.

186826-86-8
DC11273 Murepavadin (POL7080) Featured

Murepavadin is a novel class of highly specific outer membrane protein targeting antibiotic to treat resistant Pseudomonas infections.

944252-63-5
DC9723 PBTZ169 Featured

PBTZ169 is a decaprenyl-phosphoribose-epimerase (DprE1) inhibitor.

1377239-83-2
DC10441 Relebactam Featured

Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes.

1174018-99-5
DC4148 Retapamulin

Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.

224452-66-8
DCAPI1325 Rifabutin (Mycobutin)

Rifabutin (Mycobutin)

72559-06-9
DC8032 Solithromycin Featured

Solithromycin is a novel ketolide antibiotic.

760981-83-7
Page 1 / Total 2 FirstPrevNextLastGoto